Provided by Tiger Fintech (Singapore) Pte. Ltd.

LeMaitre Vascular

90.24
-0.5000-0.55%
Pre-market: 89.30-0.9400-1.04%05:56 EDT
Volume:209.77K
Turnover:18.98M
Market Cap:2.04B
PE:46.76
High:92.00
Open:91.88
Low:88.24
Close:90.74
Loading ...

Company Profile

Company Name:
LeMaitre Vascular
Exchange:
NASDAQ
Establishment Date:
1983
Employees:
658
Office Location:
63 Second Avenue,Burlington,Massachusetts,United States
Zip Code:
01803
Fax:
781 221 2223
Introduction:
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Directors

Name
Position
George W. LeMaitre
Chairman of the Board and Chief Executive Officer
David B. Roberts
President and Director
Joseph P. Pellegrino, Jr.
Chief Financial Officer and Director
Bridget A. Ross
Director
John A. Roush
Director
John J. O'Connor
Director
Lawrence J. Jasinski
Director

Shareholders

Name
Position
George W. LeMaitre
Chairman of the Board and Chief Executive Officer
Andrew Hodgkinson
Senior Vice President, Clinical, Regulatory and Quality Affairs
Joseph P. Pellegrino, Jr.
Chief Financial Officer and Director
Laurie A. Churchill
Senior Vice President and General Counsel
Trent G. Kamke
Senior Vice President, Operations
Chance Kriesel
Vice President, Sales, The Americas
David B. Roberts
President and Director
Giovannella Deiure
Vice President, Sales - Southern Europe
Helen Goulding
Director - Northern Europe
Jacob Petersen
Vice President, Asia-Pac
James Russell
Director, Operations
Jonathan W. Ngau
Vice President, Information Technology
Kimberly L. Cieslak
Vice President, Marketing
Roli Kumar Choudhury
Vice President, Quality Affairs
Ryan H. Connelly
Vice President, Research and Development
Stephane Maier
Vice President, EMEA Operations
Xiang Zhang
Vice President, Regulatory Affairs